Improvement of glycemic control without severe hypoglycemia in a type 1 diabetes patient undergoing hemodialysis after a change from insulin glargine to insulin degludec

J Diabetes Investig. 2016 Sep;7(5):805-6. doi: 10.1111/jdi.12500.

Authors

Nobuyuki Takahashi¹, Tetsuro Tsujimoto^{1

2}, Kaori Inoue¹, Miyako Kishimoto^{1

3}, Hiroshi Kajio¹

Affiliations

¹ Department of Diabetes, Endocrinology, and Metabolism, Center Hospital, National Center for Global Health and Medicine, Tokyo, Japan.
² Division of General Medicine, Jichii Medical University Graduate School of Medicine, Shimotsuke, Japan.
³ Department of Diabetes Research, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan.

Abstract

Insulin degludec improved glycemic control in a type 1 diabetes patient undergoing hemodialysis.

© 2016 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Publication types

Case Reports
Letter

MeSH terms

Blood Glucose / metabolism
Diabetes Mellitus, Type 1 / blood
Diabetes Mellitus, Type 1 / complications
Diabetes Mellitus, Type 1 / drug therapy*
Diabetic Neuropathies
Female
Humans
Hypoglycemia / complications*
Hypoglycemic Agents / therapeutic use*
Insulin Glargine / therapeutic use*
Insulin, Long-Acting / therapeutic use*
Middle Aged
Renal Dialysis
Treatment Outcome

Substances

Blood Glucose
Hypoglycemic Agents
Insulin, Long-Acting
Insulin Glargine
insulin degludec